SpaceX's $100 Billion Unlock Defies Gravity—and Basic Market Theory

On the day SpaceX released 911.5 million shares into tradable circulation—a $100 billion unlock that would ordinarily trigger the kind of panic usually reserved for earnings misses and accounting restatements—the stock climbed 6.1%. Trading volume hit 250 million shares, a new high since the company's debut week. The market had collectively decided that nearly doubling the public float from 639 million shares to 1.55 billion was, at worst, a minor inconvenience.

This is either the most bullish signal institutional confidence has sent in years, or the clearest evidence yet that equity markets have simply stopped pricing dilution events as material risks. Possibly both.

SpaceX's second-quarter earnings provided the technical justification for the unlock. Revenue of $7.8 billion crushed the Street's $6.8 billion estimate—a 92% year-over-year increase, a number that would make most aerospace contractors weep into their balance sheets. EBITDA of $3.5 billion nearly doubled the $2.1 billion consensus. The company beat on the headline metrics, which meant the lockup expiration triggered automatically, and the market's job was to absorb the supply.

What the market chose not to absorb, however, was the growing capital expenditure problem sitting in SpaceX's footnotes. Capex soared to $18.4 billion in the second quarter alone. SpaceX's CFO, in the kind of guidance that would ordinarily send traders scrambling for the exits, stated plainly that investors should expect similar capex levels in each of the next two quarters. That is roughly $55 billion in capital spending over three quarters—a velocity of cash outflow that raises unavoidable questions about future cash flow, profitability, and the company's ability to fund its growth ambitions without further dilution.

The stock fell nearly 15% on Wednesday as investors focused on exactly that math. Then came Thursday, the unlock day, and the math somehow reversed.

The mechanics are instructive. ARK Invest and retail buyers absorbed a meaningful portion of the newly available shares. Short interest in SpaceX stands at approximately 35%, a figure that creates potent covering incentives when positive momentum emerges. When a stock climbs on a day that should theoretically anchor it—when nearly a billion shares hit the market and the stock rises anyway—short positions panic. They cover. They buy. The resulting squeeze adds velocity to the move, and suddenly the narrative inverts from "dilution disaster" to "market confidence."

But narratives are cheap. The data point that matters is this: $100 billion in newly tradable shares moved into circulation, the public float more than doubled, and the stock went up. Markets are indeed forward-looking, but they are also efficient at repricing only what they believe matters. Dilution, apparently, no longer qualifies.

What does matter, according to the Thursday price action, is that SpaceX is growing revenue at double-digit rates, beating earnings expectations by material margins, and executing the capital programs required to defend its competitive position in commercial spaceflight. The unlock is secondary to that story. It is, in market terms, priced in—which is another way of saying investors have decided that growth and execution trump share count mathematics.

Roughly $800 billion in additional SpaceX shares become eligible for sale through October. The market's response to the first tranche suggests those unlocks will follow a similar pattern: initial weakness tied to external macro noise, followed by absorption and recovery. The question is not whether the market can absorb the supply. Thursday proved it can. The question is whether SpaceX can absorb the capital requirements it is forecasting. That answer arrives in quarters, not trading sessions. Until then, expect the stock to trade on momentum and execution, not math.

The CFO's capex guidance remains the real headwind. But the market has stopped penalizing headwinds. It is too busy watching growth.